GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Stanford University
OHSU Knight Cancer Institute
Stanford University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
University of Rochester
University Health Network, Toronto
City of Hope Medical Center
Indiana University
Texas Oncology Cancer Center
University of California, San Francisco
The Emmes Company, LLC
Washington University School of Medicine
Rutgers, The State University of New Jersey